LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.16 | 770.25 | 4439 | 8892 | 0.4992 | 0.6426 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.39 | 770.25 | 4052 | 9326 | 0.4345 | 0.5864 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.39 | 770.25 | 4580 | 9326 | 0.4911 | 0.6413 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.61 | 770.25 | 4252 | 9736 | 0.4367 | 0.5949 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.61 | 770.25 | 4845 | 9736 | 0.4976 | 0.6528 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.83 | 770.25 | 4409 | 10078 | 0.4375 | 0.6005 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.83 | 770.25 | 4994 | 10078 | 0.4955 | 0.6551 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.05 | 770.25 | 4573 | 10413 | 0.4391 | 0.6066 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.05 | 770.25 | 5205 | 10413 | 0.4998 | 0.6629 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.27 | 770.25 | 4719 | 10730 | 0.4398 | 0.6112 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.27 | 770.25 | 5400 | 10730 | 0.5032 | 0.6694 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.50 | 770.25 | 4924 | 10991 | 0.4480 | 0.6222 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.50 | 770.25 | 5637 | 10991 | 0.5129 | 0.6804 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.75 | 770.25 | 5018 | 11262 | 0.4455 | 0.6230 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.75 | 770.25 | 5827 | 11262 | 0.5174 | 0.6869 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.98 | 770.25 | 5199 | 11518 | 0.4514 | 0.6312 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.98 | 770.25 | 6032 | 11518 | 0.5237 | 0.6945 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.20 | 770.25 | 5324 | 11766 | 0.4525 | 0.6348 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.20 | 770.25 | 6274 | 11766 | 0.5332 | 0.7045 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.42 | 770.25 | 5397 | 12031 | 0.4486 | 0.6339 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 83.42 | 770.25 | 6494 | 12031 | 0.5397 | 0.7120 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.64 | 770.25 | 5378 | 12287 | 0.4377 | 0.6264 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 85.64 | 770.25 | 6599 | 12287 | 0.5371 | 0.7118 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 770.25 | 5455 | 12543 | 0.4349 | 0.6263 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 770.25 | 6825 | 12543 | 0.5441 | 0.7194 | MN20160304_L02 | L09 |